TESAMORELIN — 2 mg

Tesamorelin is a synthetic peptide widely studied in research settings for its selective interaction with growth hormone–releasing hormone (GHRH)–related pathways. Researchers examine it for how it stimulates endogenous growth hormone secretion, influences circadian hormone dynamics, and affects downstream metabolic and physiological markers without broadly activating other pituitary hormone systems.

Key Research Observations on Tesamorelin

Stimulation of endogenous growth hormone release
Research literature describes tesamorelin as a GHRH analog that promotes the natural release of growth hormone by acting at the pituitary level rather than supplying exogenous hormone.

Preservation of physiological hormone pulsatility
Studies note that tesamorelin supports growth hormone release in a pulsatile manner, maintaining patterns that more closely resemble endogenous circadian secretion rhythms.

Minimal impact on non–growth hormone pituitary hormones
Scientific investigations observe that tesamorelin demonstrates specificity for growth hormone pathways, with limited effects on cortisol, prolactin, or other pituitary hormones in research models.

Interest in metabolic and tissue signaling research
Academic and preclinical research examines tesamorelin for its downstream effects on lipid metabolism signaling, body composition–related pathways, and tissue-level metabolic regulation.